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Background: Most patients with single ventricle congenital heart disease (SV) are now expected to survive to adulthood. Medical comorbidities 
are common in SV.
methods: We used nationally distributed data from 43 pediatric hospitals in the 2004 to 2011 Pediatric Health Information System database 
to identify patients ≥ 18 years of age admitted to the hospital with International Classification of Diseases-9th Revision codes for a diagnosis of 
either hypoplastic left heart syndrome, tricuspid atresia or single ventricle. Primary diagnoses (PD), length of stay (LOS) and hospital charges were 
determined. Interaction of charges with PD and year of admission were examined using one-way analysis of variance.
results: There were 803 SV patients with 1333 admissions during the study period. Mean age was 24.8±6.2 years (54% male) and mean LOS 
was 6.8±11.3 days. Total hospital charges were $127 million with mean charge per admission of $95,501±192,068. Mean charge per hospital day 
was $14,765±16,574. The PD, number of admissions, hospital charges and LOS are shown in Table 1. Hospital charges correlated with PD group 
(p<0.001). Admission rate remained stable (~180/year) from 2006 to 2011. LOS decreased (p<0.0308) and hospital charges per day increased 
across the study period (p<0.001).
conclusions: The costs of hospitalizations in adults with SV are significant and are impacted by comorbid medical conditions. Hospitalization 
rates for adults with SV are not increasing, though costs are.
Effect of Principal Diagnosis Group on Hospitalization in Adults with Single Ventricles (N=1287)*
Primary Diagnosis Group
Admissions
Number (%)
Total Charges
(Millions)
Hospital Charges
Mean±SD
Length of Stay
Mean±SD
Cardiovascular 961 (72%) $107 $111,711±201,194 7.2±12.2
Gastroenterologic 86 (6%) $4.5 $52,901±91,734 6.4±8.2
Infectious disease 86 (6%) $5.6 $64,582±89,262 7.5±9.4
Pulmonary 50 (4%) $4.9 $97,889±279,819 8.5±12.8
Neurologic & Otolaryngology 41 (3%) $0.9 $24,099±32,795 3.1±3.0
Hematology & Oncology 34 (3%) $0.9 $26,909±25,965 4.0±4.8
Fluid & Electrolyte 18 (1%) $0.3 $19,141±12,781 2.8±2.6
Rheumatologic & Orthopedic 11 (1%) $1.2 $111,792±129,706 6.3±5.5
*Indicates groups with ≥10 admissions
